ALTH
Allos Therapeutics Inc
Biopharmaceutical company focused on development and commercialization of cancer therapies, notably FOLOTYN (pralatrexate) for peripheral T-cell lymphoma
CUSIP: 019777101HealthcareUS1 holder
Total Value
$3.09M
Total Shares
500.0K
Net Share Change
+500.0K
Activity
1 buying
Investor
Value
Shares
Weight
Change
